Please assess the completion status of the following clinical trial:

Trial Title: Focus on Fibre Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* healthy but overweight/obese (BMI 28-40kg/m2) males and females (post-menopausal, using the oral contraceptive pill or some form of hormonal contraceptive)~* low habitual fibre intake (\<10g/day)~Exclusion Criteria:~Medication exclusion criteria:~* antibiotic use (within the past 3 months due to impact on gut microbiota)~* statins (current)~* aspirin or other NSAIDs or anti-coagulants (current)~* anti-depressants (current)~* smoking or vaping~Medical exclusion criteria:~* Females who are planning to be pregnant, are pregnant or are breastfeeding~* Anyone with food allergies, self-reported food sensitivity or intolerance~* Anyone with coeliac disease or gluten intolerance~* Anyone taking medication which may affect their appetite~* Anyone with an eating disorder~* Anyone with diabetes~* Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout~* Anyone suffering from a psychiatric disorder or any type of substance abuse~* Anyone suffering from unregulated thyroid disease~Other exclusion criteria:~* Anyone following a vegetarian or vegan diet~* Anyone following a weight loss programme (that may be affecting lifestyle, physical activity \& diet)~* Anyone with unsuitable veins for blood sampling~* Anyone who is unable to fluently speak, read and understand English~* Anyone who is unable to comply to an alcohol-free diet for 6 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control - High Fibre - Low Fibre (CTRL - HF - LF) (Type: EXPERIMENTAL): * Phase 1 - CTRL: Control diet with moderate fibre consumption for 13days.~* Phase 2 - HF: ad libitum consumption of HF meals for 13days.~* Phase 3 - LF: ad libitum consumption of LF meals for 13days.

Based on this trial design, predict the completion outcome and termination type (if applicable).